ChartMill assigns a Buy % Consensus number of 84% to ANIP. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-12-09 | Barclays | Initiate | Overweight |
| 2025-11-10 | Guggenheim | Maintains | Buy -> Buy |
| 2025-10-09 | Truist Securities | Maintains | Hold -> Hold |
| 2025-09-24 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-09-17 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-09-08 | Guggenheim | Maintains | Buy -> Buy |
| 2025-08-11 | Truist Securities | Maintains | Hold -> Hold |
| 2025-08-08 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-07-10 | HC Wainwright & Co. | Initiate | Buy |
| 2025-05-12 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-04-21 | Truist Securities | Maintains | Hold -> Hold |
| 2025-04-11 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-03-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-14 | Jefferies | Initiate | Buy |
| 2025-03-12 | JP Morgan | Initiate | Overweight |
| 2025-03-05 | Guggenheim | Maintains | Buy -> Buy |
| 2025-03-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-11 | Leerink Partners | Initiate | Outperform |
| 2024-11-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-22 | Truist Securities | Maintains | Hold -> Hold |
| 2024-10-11 | Piper Sandler | Initiate | Overweight |
| 2024-09-18 | Raymond James | Maintains | Outperform -> Outperform |
| 2024-09-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-11 | Truist Securities | Downgrade | Buy -> Hold |
| 2024-08-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-26 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-05-13 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-04-23 | Guggenheim | Reiterate | Buy -> Buy |
| 2024-03-15 | Capital One | Initiate | Overweight |
| 2024-03-05 | Guggenheim | Maintains | Buy -> Buy |
14 analysts have analysed ANIP and the average price target is 111.33 USD. This implies a price increase of 37.27% is expected in the next year compared to the current price of 81.1.
The consensus rating for ANI PHARMACEUTICALS INC (ANIP) is 84.2857 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering ANI PHARMACEUTICALS INC (ANIP) is 14.